Treatment of Hidradenitis Suppurativa Using Etanercept

Treatment of Hidradenitis Suppurativa Using Etanercept


Treatment of Hidradenitis Suppurativa Using Etanercept

Acronym: null
Other IDs: 20031168
NCT Number: NCT00949546
Sponsor Collaborators: Penn State University|Amgen
Funding: Other|Industry


HIDRADENITIS SUPPURATIVA CLINICAL TRIAL STATUS

Recruiting Status: Completed
Recruiting Genders: Both
Recruiting Age Groups: Adult|Senior
Interventions: Drug: etanercept
Phases:


CLINICAL STUDY DETAILS & RESULTS

STUDY TYPES: Observational
STUDY DESIGNS: Observational Model: Cohort|Time Perspective: Prospective
Results First Received: No Study Results Posted
Study Result (if available): No Results Available
Primary Completion Date: null
Outcome Measures: Physician global assessment of HS of clear or mild at week 12


CLINICAL STUDIES DATES & MILESTONES

First Received: July 29, 2009
Start Date: April 2005
Completion Date: January 2008
Last Updated: July 29, 2009
last Verified: July 2009


Source: https://ClinicalTrials.gov/show/NCT00949546


Public Domain Source: ClinicalTrials.gov query for “Hidradenitis suppurativa” clinical studies (last updated January 2016).


Tags:
0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?